A Pathway to Putting Patients First: Spotlight on TAAR1 Agonists for Treating Schizophrenia

Target Audience
This activity is designed for psychiatrists, advanced practice psychiatric nurses, and other mental health care professionals who care for patients with schizophrenia.

Program Overview
In this activity, two expert faculty members " a psychiatric nurse and a psychiatrist " will give you the opportunity to learn about unmet needs in the management of schizophrenia, including outcomes that are important to patients, the role of psychiatric nurses in schizophrenia care, adverse effects of antipsychotics and their impact on patients’ lives, and the latest clinical data on TAAR1 agonists. Importantly, you will also hear from a patient advocate living with schizophrenia. She will share the daily reality of what living with “unmet needs” and antipsychotic adverse effects looks like, as well as her hope for the future.

Learning Goal/Purpose
The goal of this educational activity is to enhance clinicians’ knowledge of unmet needs in schizophrenia care, familiarize them with the role of psychiatric nurses in improving patient outcomes, and update them on the latest clinical data regarding TAAR1 agonists.